Recent research reveals a relationship between sleep disturbances, the orexinergic system, and cognitive decline in Alzheimer’s Disease (AD), highlighting the potential of orexin receptors 1 and 2 (OX1R and OX2R) as promising new targets for AD therapeutic intervention. In this project, we have used virtual screening and structure-based drug design to identify potential molecular photoswitches for OX1R and OX2R. Photoswitches undergo conformational changes upon light exposure, potentially altering their pharmacological effects. This offers a way to regulate orexin receptor activity in a specific and reversible manner, providing a powerful research tool for studying the orexin receptor's role in AD and...